Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74M Buy
32,418
+2,000
+7% +$161K 0.08% 216
2026
Q1
$2.15M Sell
30,418
-2,200
-7% -$165K 0.07% 238
2025
Q4
$2.57M Sell
32,618
-2,030
-6% -$161K 0.09% 209
2025
Q3
$2.85M Buy
34,648
+657
+2% +$51.7K 0.1% 191
2025
Q2
$2.73M Buy
33,991
+1,141
+3% +$88K 0.11% 184
2025
Q1
$2.64M Buy
32,850
+2,603
+9% +$216K 0.11% 187
2024
Q4
$2.48M Buy
30,247
+755
+3% +$62.8K 0.19% 143
2024
Q3
$2.43M Sell
29,492
-2,206
-7% -$165K 0.18% 146
2024
Q2
$2.22M Sell
31,698
-7,803
-20% -$557K 0.18% 153
2024
Q1
$2.93M Sell
39,501
-744
-2% -$51.9K 0.26% 104
2023
Q4
$2.76M Buy
40,245
+999
+3% +$62.5K 0.26% 97
2023
Q3
$2.33M Sell
39,246
-4,588
-10% -$286K 0.26% 104
2023
Q2
$2.78M Buy
43,834
+1,116
+3% +$61.9K 0.31% 91
2023
Q1
$2.48M Sell
42,718
-9,903
-19% -$668K 0.26% 100
2022
Q4
$3.81M Sell
52,621
-984
-2% -$70.5K 0.45% 51
2022
Q3
$3.92M Sell
53,605
-1,505
-3% -$96.1K 0.48% 48
2022
Q2
$3.49M Buy
55,110
+472
+0.9% +$31.2K 0.42% 61
2022
Q1
$3.84M Sell
54,638
-1,162
-2% -$78.6K 0.45% 62
2021
Q4
$3.66M Buy
+55,800
New +$3.5M 0.47% 60

Other funds holding MET

Ascent Group's MET Position: Q2 2026 in Review

Ascent Group increased its MetLife (MET) stake by 6.6% in Q2 2026, buying an estimated $161K and bringing the position to 32,418 shares worth $2.74M. The position accounts for 0.08% of the portfolio, ranked #216.

Ascent Group first reported a position in MET in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.92M in Q3 2022. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Ascent Group held 32,418 shares of MetLife worth $2.74M as of Q2 2026.
  • Ascent Group bought 2,000 MetLife shares in Q2 2026, an estimated $161K.
  • MetLife made up 0.08% of Ascent Group's portfolio in Q2 2026, its #216 holding.
  • Ascent Group first reported a position in MetLife in Q4 2021 and has held it in 19 quarters since.
  • Ascent Group's MetLife position peaked at $3.92M in Q3 2022.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.